Intracoronary Stent Used in a Transplanted Heart

Area of Science:

• Cardiology
• Transplantation Immunology
• Interventional Cardiology

Background:

• Cardiac allograft vasculopathy (CAV) is a unique form of coronary artery disease following heart transplantation.
• CAV pathogenesis and optimal treatment strategies remain incompletely understood.
• Early detection and intervention are crucial for long-term graft survival.

Purpose of the Study:

• To report a case of significant coronary artery disease in a heart transplant recipient.
• To illustrate the successful application of coronary angioplasty and stenting for CAV.
• To highlight the role of advanced imaging in assessing stent patency.

Main Methods:

• A 53-year-old male heart transplant recipient presented with symptoms of myocardial ischemia.
• Coronary angiography revealed significant two-vessel coronary artery disease.
• Percutaneous coronary intervention with Palmaz-Schatz stent implantation was performed in the left anterior descending artery.
• Ultrafast computed tomography and follow-up angiography were used to assess stent patency.

Main Results:

• Successful coronary angioplasty and stenting of the left anterior descending artery were achieved.
• The implanted Palmaz-Schatz stent remained patent at three-month follow-up.
• Ultrafast computed tomography provided effective visualization of stent patency.

Conclusions:

• Coronary artery disease in heart transplant recipients can be effectively managed with interventional techniques.
• Stenting, specifically with Palmaz-Schatz stents, offers a viable treatment option for significant CAV.
• Multimodality imaging plays a key role in monitoring treatment success in CAV patients.